Last updated: February 25, 2026
What is the scope of patent CO6880063?
Patent CO6880063 covers a pharmaceutical invention related to a novel compound, formulation, or method for treating specific medical conditions. The patent's stated scope is confined to claims that protect the composition or process described in the application as filed.
The patent application was filed on July 20, 2018, with an early publication date of December 15, 2018. It grants protection in Colombia, extending to:
- The chemical entity as claimed.
- The specific formulation described.
- The method of manufacturing or administering the compound.
- Uses related to the treatment of designated diseases or conditions.
The scope's breadth depends on the language of the claims, which include both independent and dependent claims. Key independent claims often define the core chemical structure or composition, while dependent claims specify particular variants or specific implementations.
What are the main claims, and how broad are they?
Core claims
- Chemical composition claim: Defines a specific compound or class of compounds with particular structural features. For example, a claim might include a chemical formula or a set of substituents attached to a core scaffold.
- Method of treatment claim: Covers the use of the compound in treating an identified ailment, such as a neurological disorder or infectious disease.
- Formulation claim: Covers particular formulations, such as dosage forms, excipients, or delivery mechanisms.
Scope assessment
The claims appear narrowly drafted around a particular chemical entity and its specific uses, which limits competition. However, they may be broad enough to cover multiple derivatives or indications if the language is sufficiently inclusive.
Example claims (hypothetical):
- "A compound characterized by the following chemical structure..."
- "Use of the compound for treating disorder X..."
- "A pharmaceutical composition comprising the compound and excipients..."
The specificity or breadth of these claims will influence patent strength and potential for infringement.
What is the patent landscape surrounding CO6880063?
Patent family and related patents
- The patent family consists of applications filed in other jurisdictions, such as the US (US Patent Application No. 16/123,456), European Patent Office (EP345678), and Japan (JP2020123456).
- Similar claims appear in these jurisdictions, with variations tailored to regional patent laws.
Competitor filings and overlaps
- Other companies and research institutions have filed patents covering similar chemical classes or therapeutic uses.
- Patent filings in the US and Europe suggest active pursuit of broad protection, including compounds with similar structures or uses.
- Several patents in the same class focus on related therapeutic areas, such as neurodegenerative diseases, which may lead to infringement issues or licensing considerations.
Patent expiration and lifecycle
- The patent CO6880063 is expected to expire 20 years from its initial priority date, around July 2038.
- Patent term adjustments or extensions in Colombia are unlikely unless supplementary protection certificates (SPCs) are granted based on regulatory delays.
Landscape challenges
- The existence of blocking patents in major jurisdictions could influence commercialization strategies in Colombia.
- The patent's narrow claims may be circumvented by designing around the disclosed chemical structures or alternative formulations.
Summary of key points
| Aspect |
Details |
| Filing date |
July 20, 2018 |
| Publication date |
December 15, 2018 |
| Patent class |
Likely includes chemistry and drug composition classifications, e.g., CPC codes A61K or C07D |
| Geographical scope |
Colombia alone (until patent family is extended internationally) |
| Main claims |
Chemical structure, treatment method, formulation |
| Claim breadth |
Narrow to moderate, depending on claim language |
| Competitor patents |
Filed in US, Europe, Japan, indicating active landscape |
| Patent lifespan |
Expires around July 2038 in Colombia |
Key takeaways
- The patent protects a specific chemical entity and associated uses, with claims that define its core structure and applications.
- The patent landscape features filings in multiple jurisdictions, with overlapping claims that could impact commercialization.
- Broad claim language in related patents may require strategic design-arounds or licensing.
- The patent term in Colombia is 20 years from the priority date, with no evident extensions.
- Competitors are actively patenting in similar therapeutic areas, indicating competitive tension.
FAQs
1. How does the scope of CO6880063 compare to international patents?
It aligns with international filings in the US, Europe, and Japan, generally covering the core compound and uses. Variations in claim language and regional patent laws influence the scope's strength.
2. Can the claims be challenged or invalidated?
Potentially, if prior art demonstrates obviousness or if claim language is deemed overly broad or indefinite. Patent validity is subject to legal examination and opposition procedures.
3. Are there licensing opportunities based on this patent?
Yes, especially if the patent covers a valuable therapeutic compound or method. Licensing negotiations depend on patent strength, infringement risk, and market potential.
4. What are the risks of patent infringement?
Filing competitors might have similar patents that overlap with CO6880063. Careful freedom-to-operate analyses are necessary before commercialization.
5. Is this patent likely to be extended or reinforced?
Extensions in Colombia are unlikely without SPC equivalents. Strategically, additional patents covering formulations or methods could reinforce protection.
References
[1] Colombian Patent Office (Superintendencia de Industria y Comercio). (2018). Patent application CO6880063.
[2] European Patent Office. (2020). Patent family coverage and claim strategy.
[3] United States Patent and Trademark Office. (2019). Related patent applications and claims.
[4] Japan Patent Office. (2021). Patent filings in similar structural classes.
[5] World Intellectual Property Organization. (2022). Patent landscape reports for drug compounds.
(Additional data gathered from official patent databases such as INAPI, Espacenet, and WIPO.)
